Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-20 Sale |
2025-03-21 4:53 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
55,000 | $16.69 | $918,060 | 314,017 (Indirect Direct) |
View |
| 2025-03-03 Purchase |
2025-03-05 4:17 pm |
CLARIVATE PLC | CLVT | SAHA SAURABH Director |
58,275 | $4.36 | $254,079 | 82,016 (Direct) |
View |
| 2025-02-20 Sale |
2025-02-20 5:45 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
55,000 | $15.93 | $876,088 | 369,017 (Indirect Direct) |
View |
| 2025-01-21 Sale |
2025-01-22 4:15 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
55,000 | $15.77 | $867,430 | 467,398 (Indirect Direct) |
View |
| 2024-12-20 Sale |
2024-12-20 5:22 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
55,000 | $17.44 | $959,057 | 558,661 (Indirect Direct) |
View |
| 2024-12-06 Sale |
2024-12-06 5:03 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
87,496 | $18.46 | $1,615,255 | 4,483,146 (Indirect Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 4:22 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
299 | $18.23 | $5,451 | 4,570,642 (Indirect Direct) |
View |
| 2024-11-20 Sale |
2024-11-22 5:06 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
60,182 | $17 | $1,023,226 | 8,529,892 (Indirect Direct) |
View |
| 2024-11-13 Sale |
2024-11-15 4:30 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
32,023 | $18.28 | $585,419 | 4,631,123 (Indirect Direct) |
View |
| 2024-10-21 Sale |
2024-10-23 5:27 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
55,000 | $15.7 | $863,727 | 668,661 (Indirect Direct) |
View |
| 2024-09-20 Sale |
2024-09-20 4:55 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
55,000 | $16.53 | $908,985 | 759,924 (Indirect Direct) |
View |
| 2024-09-10 Sale |
2024-09-12 8:01 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
175,000 | $16.52 | $2,891,823 | 4,809,409 (Indirect Direct) |
View |
| 2024-08-30 Sale |
2024-09-04 4:51 pm |
CLARIVATE PLC | CLVT | SAHA SAURABH Director |
17,646 | $6.75 | $119,111 | 23,741 (Direct) |
View |
| 2024-08-23 Sale |
2024-08-23 5:13 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
46,651 | $12.3 | $573,905 | 814,924 (Indirect Direct) |
View |
| 2024-08-20 Sale |
2024-08-22 5:15 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
8,349 | $12.28 | $102,546 | 861,575 (Indirect Direct) |
View |
| 2022-06-24 Purchase |
2022-06-27 9:28 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
10,000 | $4.6284 | $46,284 | 38,000 (Indirect) |
View |
| 2022-02-02 Purchase |
2022-02-04 08:30 am |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
5,000 | $9.74 | $48,700 | 28,000 (Indirect) |
View |
| 2021-11-16 Purchase |
2021-11-18 7:00 pm |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
23,000 | $12.28 | $282,472 | 23,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-01 Tax Withholding |
2025-02-04 4:56 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
43,381 | $16.92 | 1,324,017 (Direct) |
View |
| 2025-02-03 Option Award |
2025-02-04 4:56 pm |
N/A 2035-02-03 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
900,000 | $0 | 1,324,017 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2024-12-31 4:31 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
36,263 | $16.35 | 522,398 (Direct) |
View |
| 2024-12-06 Exercise |
2024-12-06 5:03 pm |
N/A 2031-02-19 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
87,496 | $0 | 4,483,146 (Direct) |
View |
| 2024-12-06 Exercise |
2024-12-06 5:03 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
87,496 | $5.84 | 4,483,146 (Direct) |
View |
| 2024-11-25 Exercise |
2024-11-27 4:22 pm |
N/A 2031-02-19 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
299 | $0 | 4,570,642 (Direct) |
View |
| 2024-11-25 Exercise |
2024-11-27 4:22 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
299 | $5.84 | 4,570,642 (Direct) |
View |
| 2024-11-21 Exercise |
2024-11-22 5:06 pm |
N/A 2031-02-19 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
5,182 | $0 | 8,529,892 (Direct) |
View |
| 2024-11-21 Exercise |
2024-11-22 5:06 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
5,182 | $5.84 | 8,529,892 (Direct) |
View |
| 2024-11-13 Exercise |
2024-11-15 4:30 pm |
N/A 2031-02-19 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
32,023 | $0 | 4,631,123 (Direct) |
View |
| 2024-11-13 Exercise |
2024-11-15 4:30 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
32,023 | $5.84 | 4,631,123 (Direct) |
View |
| 2024-09-30 Tax Withholding |
2024-10-02 4:31 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
36,263 | $15.79 | 723,661 (Direct) |
View |
| 2024-09-10 Exercise |
2024-09-12 8:01 pm |
N/A 2031-02-19 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
175,000 | $0 | 4,809,409 (Direct) |
View |
| 2024-09-10 Exercise |
2024-09-12 8:01 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
175,000 | $5.84 | 4,809,409 (Direct) |
View |
| 2024-06-30 Tax Withholding |
2024-07-02 4:32 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
36,263 | $9.03 | 869,924 (Direct) |
View |
| 2024-05-06 Tax Withholding |
2024-05-08 4:34 pm |
N/A N/A |
CLARIVATE PLC | CLVT | SAHA SAURABH Director |
4,412 | $7.05 | 41,387 (Direct) |
View |
| 2024-05-07 Option Award |
2024-05-08 4:34 pm |
N/A N/A |
CLARIVATE PLC | CLVT | SAHA SAURABH Director |
23,741 | $0 | 41,387 (Direct) |
View |
| 2024-03-31 Tax Withholding |
2024-04-02 4:17 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
36,263 | $11.3 | 906,187 (Direct) |
View |
| 2024-02-01 Tax Withholding |
2024-02-02 5:07 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
26,323 | $8.19 | 1,519,250 (Direct) |
View |
| 2024-02-01 Option Award |
2024-02-02 5:07 pm |
N/A 2034-02-01 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
721,000 | $0 | 1,519,250 (Direct) |
View |
| 2023-12-31 Tax Withholding |
2024-01-02 7:43 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
36,263 | $7.96 | 824,573 (Direct) |
View |
| 2023-09-30 Tax Withholding |
2023-10-03 4:53 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
36,263 | $6.47 | 860,836 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-03 5:32 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
36,263 | $5.9001 | 897,099 (Direct) |
View |
| 2023-05-04 Option Award |
2023-05-08 5:10 pm |
N/A N/A |
CLARIVATE Plc | CLVT | SAHA SAURABH Director |
22,058 | $0 | 22,058 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:03 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
22,013 | $3.9 | 933,362 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 5:10 pm |
N/A 2033-02-01 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
526,400 | $0 | 1,270,375 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-04 7:25 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
44,025 | $3.1 | 743,975 (Direct) |
View |
| 2022-07-01 Option Award |
2022-07-06 6:16 pm |
N/A N/A |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
750,000 | $0 | 788,000 (Direct) |
View |
| 2022-02-01 Option Award |
2022-02-03 6:30 pm |
N/A 2032-02-01 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
750,000 | $0 | 750,000 (Direct) |
View |
Ownership |
2021-05-27 8:32 pm |
N/A 2031-02-19 |
Centessa Pharmaceuticals plc | CNTA | SAHA SAURABH Chief Executive Officer |
0 | $0 | 4,169,485 (Direct) |
View |